Mannkind Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Mannkind's inventory turnover ratio sequentially decreased to 1.64 in the first quarter 2026, unsurprisingly, as the Mannkind markets continue to deteriorate, and MNKD's faces growing challenges to bring down its inventories. Mannkind's average inventory processing period in the Mar 31 2026 quarter, has increased to 223 days, from 179 days, in the Dec 31 2025 quarter.

Within Healthcare sector 239 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1087 in the fourth quarter 2025, to 1618.

MNKD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Mannkind Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MNKD Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	70.17 %	26.63 %	1.16 %	15.1 %	9.27 %
Y / Y Cost of Sales Growth	-27.52 %	6.42 %	5.93 %	8.05 %	-6.98 %
Inventory Turnover Ratio (TTM)	1.64	2.04	2.15	2.12	2.15
MNKD's Total Ranking	# 1618	# 1087	# 946	# 1136	# 748
Average inventory processing period	223	179	170	172	170
Seq. Inventory Growth	39.23 %	30.92 %	-5.33 %	-1.39 %	3.61 %
Seq. Cost of Sales Growth	-36.72 %	0.26 %	-1.6 %	16.1 %	-7.08 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 64
Healthcare Sector	# 240
Overall Market	# 1618

Inventory Turnover Ratio Statistics
High	Average	Low
7.95	3.46	0.9
(Dec 31 2018)		(Sep 30 2015)

MNKD Company Profile >> Back to MNKD Efficiency Comparisons >> Compare MNKD Inventory Turnover Ratio to its Competitors

Financial Statements
Mannkind's Inventories	$ 49 Millions	Visit MNKD's Balance sheet
Mannkind's Cost of Revenues TTM	$ 57 Millions	Visit MNKD's Income Statement
What are MNKD's Sales?		Visit MNKD's Sales by Segment

Other Inventory Turnover Ratios
Mannkind's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MNKD's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MNKD's Competitors
Inventory Turnover Ratio for MNKD's Suppliers
Inventory Turnover Ratio for MNKD's Customers

You may also want to know
MNKD's Sales Growth Rates	MNKD's Pe Price to earnings ratio	MNKD's Receivables Turnover Ratio	MNKD's Stock Quote
MNKD's Net Income Growth Rates	MNKD's Ps Price to Sales ratio	MNKD's Sales per Employee	MNKD's Asset Turnover Ratio
MNKD's Net Margin	MNKD's Pb Price to Book ratio	MNKD's Financial Strength Ratios	MNKD's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
10x Genomics Inc	3.21	$ 193.000 Millions	$ 60 Millions
Prestige Consumer Healthcare Inc	3.19	$ 493.000 Millions	$ 155 Millions
Iovance Biotherapeutics inc	3.14	$ 165.941 Millions	$ 53 Millions
Lftd Partners Inc	3.12	$ 28.258 Millions	$ 9 Millions
Beyond Air Inc	3.07	$ 6.521 Millions	$ 2 Millions
Bausch Health Companies Inc	3.07	$ 2,987.000 Millions	$ 974 Millions
Indivior Pharmaceuticals Inc	3.03	$ 242.000 Millions	$ 80 Millions
Amneal Pharmaceuticals Inc	3.02	$ 1,868.000 Millions	$ 618 Millions
Logicmark Inc	3.01	$ 3.826 Millions	$ 1 Millions
Mettler toledo International Inc	3.01	$ 1,189.678 Millions	$ 395 Millions
Revvity Inc	3.00	$ 1,151.379 Millions	$ 384 Millions
Cannapharmarx Inc	2.98	$ 2.921 Millions	$ 1 Millions
Becton Dickinson And Company	2.97	$ 11,368.000 Millions	$ 3,821 Millions
Dexcom Inc	2.97	$ 1,854.000 Millions	$ 624 Millions
Msa Safety Inc	2.93	$ 1,020.000 Millions	$ 349 Millions
Nexgel Inc	2.92	$ 6.000 Millions	$ 2 Millions
Abbott Laboratories	2.91	$ 19,741.000 Millions	$ 6,785 Millions
Zai Lab Limited	2.91	$ 128.112 Millions	$ 44 Millions
Mimedx Group Inc	2.87	$ 74.000 Millions	$ 26 Millions
Dentsply Sirona Inc	2.82	$ 1,880.000 Millions	$ 666 Millions
Catalyst Pharmaceuticals Inc	2.82	$ 83.817 Millions	$ 30 Millions
Evofem Biosciences Inc	2.82	$ 4.662 Millions	$ 2 Millions
Livanova Plc	2.80	$ 464.684 Millions	$ 166 Millions
Orthofix Medical Inc	2.79	$ 242.580 Millions	$ 87 Millions
Lifecore Biomedical Inc	2.76	$ 89.000 Millions	$ 32 Millions
Zeo Scientifix Inc	2.76	$ 1.291 Millions	$ 0 Millions
Akebia Therapeutics Inc	2.76	$ 44.127 Millions	$ 16 Millions
Biomerica Inc	2.72	$ 4.142 Millions	$ 2 Millions
Nephros Inc	2.71	$ 8.000 Millions	$ 3 Millions
Neogen Corporation	2.70	$ 478.000 Millions	$ 177 Millions

Date modified: 2026-08-30T14:45:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.